Funke Todd, Healy-Fried Martha L, Han Huijong, Alberg David G, Bartlett Paul A, Schönbrunn Ernst
Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66045, USA.
Biochemistry. 2007 Nov 20;46(46):13344-51. doi: 10.1021/bi701095u. Epub 2007 Oct 25.
The shikimate pathway enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSP synthase or EPSPS) is best known as the target of the herbicide glyphosate. EPSPS is also considered an attractive target for the development of novel antibiotics since the pathogenicity of many microorganisms depends on the functionality of the shikimate pathway. Here, we have investigated the inhibitory potency of stable fluorinated or phosphonate-based analogues of the tetrahedral reaction intermediate (TI) in a parallel study utilizing class I (glyphosate-sensitive) and class II (glyphosate-tolerant) EPSPS. The (R)-difluoromethyl and (R)-phosphonate analogues of the TI are the most potent inhibitors of EPSPS described to date. However, we found that class II EPSPS are up to 400 times less sensitive to inhibition by these TI analogues. X-ray crystallographic data revealed that the conformational changes of active site residues observed upon inhibitor binding to the representative class I EPSPS from Escherichia coli do not occur in the prototypical class II enzyme from Agrobacterium sp. strain CP4. It appears that because the active sites of class II EPSPS do not possess the flexibility to accommodate these TI analogues, the analogues themselves undergo conformational changes, resulting in less favorable inhibitory properties. Since pathogenic microorganisms such as Staphylococcus aureus utilize class II EPSPS, we conclude that the rational design of novel EPSPS inhibitors with potential as broad-spectrum antibiotics should be based on the active site structures of class II EPSP synthases.
莽草酸途径的酶5-烯醇丙酮酸莽草酸-3-磷酸合酶(EPSP合酶或EPSPS)最为人所知的是除草剂草甘膦的作用靶点。由于许多微生物的致病性取决于莽草酸途径的功能,EPSPS也被认为是开发新型抗生素的一个有吸引力的靶点。在这里,我们在一项平行研究中研究了四面体反应中间体(TI)的稳定氟化或膦酸酯类似物对I类(对草甘膦敏感)和II类(对草甘膦耐受)EPSPS的抑制效力。TI的(R)-二氟甲基和(R)-膦酸酯类似物是迄今为止所描述的EPSPS最有效的抑制剂。然而,我们发现II类EPSPS对这些TI类似物抑制作用的敏感性低至400倍。X射线晶体学数据显示,抑制剂与来自大肠杆菌的代表性I类EPSPS结合时观察到的活性位点残基的构象变化,在来自农杆菌属菌株CP4的典型II类酶中并未发生。似乎由于II类EPSPS的活性位点不具备容纳这些TI类似物的灵活性,这些类似物自身会发生构象变化,导致抑制特性变差。由于诸如金黄色葡萄球菌等致病微生物利用II类EPSPS,我们得出结论,具有作为广谱抗生素潜力的新型EPSPS抑制剂的合理设计应基于II类EPSP合酶的活性位点结构。